focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPIX.L Regulatory News (PPIX)

  • There is currently no data for PPIX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

13 Aug 2012 07:00

RNS Number : 8300J
ProPhotonix Limited
13 August 2012
 



 

13 August 2012

 

 

ProPhotonix Limited

 ("ProPhotonix" or "the Company")

 

INTERIM RESULTS FOR THE HALF YEAR ENDED 30 JUNE 2012

 

ProPhotonix Limited (London Stock Exchange - AIM: PPIX and PPIR, OTC: STKR.PK), a designer and manufacturer of LED light engines and laser diode modules with operations in Ireland and the U.K., today announces its unaudited interim results for the six months ended 30 June 2012.

 

Financial Highlights

·; Revenue decreased 24% to $6.8 million (FY 2011: $8.9 million); majority of reduction due to decline in solar sales

·; LED revenue decreased 37% to $2.9 million (FY 2011: $4.7 million)

·; Gross profit decreased 39.2% to $2.1 million (FY 2011: $3.5 million)

·; Gross profit margin lower at 31.1% (FY 2011: 38.9%)

·; Operating loss increased to $1.7 million (FY 2011: loss of $0.2 million)

·; EBITDA loss of $1.4 million vs. EBITDA of $0.3 million in 2011

·; Order bookings of $7.7 million (FY 2011: $9.6 million)

·; Percentage revenue by market sectors: industrial 76%, medical 17%, and homeland security & defense 7%

·; Percentage revenue by geography: 57% Europe, 28% North America and 15% Rest of World

·; Cash balances of $2.9 million (30 June 2011: $0.6 million)

 

Operational Highlights

 

·; Global sales force staffing in USA, UK, Germany and Switzerland completed July 2012

·; Sales distributors appointed in Germany, Taiwan and the USA

·; Introduction of expanded line of high performance LED illuminators for OEMs and machine vision market in June 2012

 

Mark W. Blodgett, Chairman & CEO, Commented:

 

"Despite a number of accomplishments during the first half of the year, the period was challenging due to the previously reported dramatic decline in the Company's sales of LED systems to solar equipment manufacturers which started in the autumn of 2011. The loss of the solar business, which now represents less than 2% of sales versus 15%, derives from excess capacity in the solar industry. With the build-out of our global sales force over the last seven months, we are moving expeditiously to replace solar sales and we are pleased with the positive book to bill for the first half of the year. Since the expansion of the sales organisation, North American laser and diode bookings are up 37% versus the first half of 2011.

 

"In the meantime, management continues aggressively to manage costs and excluding planned sales expenditures which increased 25% year over year, other operating expenses declined in the first half versus the prior year 2011. Furthermore, customer activity is increasing and our engineering team has never been busier working on new OEM driven opportunities. With the expansion of the sales force, we expect a significant sequential increase in revenues in the second half of the year versus the first half of 2012 and a corresponding improvement in overall financial performance of the Company," added Blodgett.

 

 

Enquiries:

 

 

ProPhotonix Limited

Mark W. Blodgett, CEO

 

Tel: +44 (0)12 7971 7170

ir@prophotonix.com

N+1 Brewin

Andrew Craig/ Ben Wright

 

XCAP Securities plc (Joint Broker)

Jon Belliss

 

Tel: +44 (0)20 3201 3710

 

 

Tel: +44 (0) 207 101 7070

 

Cubitt Consulting

Nicholas Nelson/Madeline Douglas

Tel: +44 (0) 20 7367 5100

 

 

 

 

About ProPhotonix

 

ProPhotonix Limited, (formerly StockerYale, Inc.) headquartered in Salem, New Hampshire, is an independent designer and manufacturer of diode-based laser modules and LED systems for industry leading OEMs and medical equipment companies. In addition, the Company distributes premium diodes for Opnext, QSI, Sanyo, and Sony. The Company serves a wide range of markets including the machine vision, industrial inspection, defense, sensors, and medical markets. ProPhotonix has offices and subsidiaries in the U.S., Ireland, U.K., and Europe. For more information about ProPhotonix and its innovative products, visit the Company's web site at www.prophotonix.com.

 

 

Half Year 2012 Financial Results

 

Revenue for the half year ended 30 June 2012 was $6.8 million, a decrease of 24% compared with $8.9 million in 2011. Gross profit was $2.1 million, a decrease of 39% compared to $3.5 million in 2011. Gross profit margin decreased to 31.1% from 38.9% in 2011 due to a shift in product mix and lower volumes. The decline in sales, gross profit and margin rate was principally due to absence of sales to several large German solar equipment customers. Foreign currency exchange negatively impacted gross profit margin by $0.2 million.

 

Operating expenses, excluding intangible amortization charges, totaled $3.7 million versus $3.5 million in 2011. Consistent with our objectives, sales and marketing and research and development (R&D) expenses increased 15% in 2012 over 2011, while general and administrative expenses declined 2% over the same period. The operating loss was $1.7 million, as compared to a $0.2 million loss in 2011. EBITDA was a loss of $1.4 million versus EBITDA in 2011 of $0.3 million. Net loss was $1.8 million compared to the 2011 net loss of $0.5 million.

 

Strategy and Markets

 

ProPhotonix consists of two business units: an LED systems manufacturing business based in Ireland (Cork), and a laser modules production and laser diode distribution division located in the United Kingdom (Hatfield Broad Oak). Corporate, marketing and the North American sales activities are based in Salem, New Hampshire, United States of America.

 

The Company is well positioned to make significant progress on in its strategy to combine its expertise in two key areas of optics: LEDs and lasers. The Company intends to capitalise on increasing opportunities in this area by designing and manufacturing high value, high margin components for global manufacturers of equipment.

 

As announced last week the Company has completed the strategic build out of its global sales force, which now totals 14 personnel. These include experienced regional sales managers based in the US, UK, Germany and Switzerland where they can better service the majority of existing and potential customers. In addition, the Company has expanded its network of distributors mostly in Asia and smaller European markets.

 

The Company has made significant investments in R&D, including expanding its R&D team in Cork, which now includes a full complement of optical, mechanical and electrical engineers and represents over 20% of the Company's total workforce of 96 employees. They are focused on continuing to develop proprietary products to meet clearly defined demand from our customers and the markets which we serve. In this regard, progress during the first half included the launch of an expanded LED illuminator product line and the development of a range of new laser module and LED OEM opportunities. Currently, the majority of the Company's R&D and product development activities are specifically tied to future customer requirements.

 

 

 

 

 

 

 

 

 

 

 

PROPHOTONIX LIMITED

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

In thousands except share and per share data

(unaudited)

 

Six Months EndedJune 30,

 

2012

 

2011

 

Revenue..............................................................................................................................................

$ 6,787

$ 8914

Cost of sales.......................................................................................................................................

4,679

5,449

 

 

Gross profit.............................................................................................................................

2,108

3,465

 

 

Operating expenses:

Selling expenses................................................................................................................................

1,446

1,160

General and administrative...............................................................................................................

1,839

1,869

Research and development..............................................................................................................

428

473

Amortization of intangibles.............................................................................................................

60

156

 

 

Total operating expenses.................................................................................................................

3,773

3,658

 

 

Loss from operations........................................................................................................................

(1,665)

(193)

Other (income) / expense, net..........................................................................................................

(22)

6

Interest expense.................................................................................................................................

142

191

 

 

Loss from continuing operations before income tax provision (benefit)..................................

(1785)

(390)

Income tax provision (benefit).........................................................................................................

(29)

73

 

 

Loss from continuing operations....................................................................................................

(1,756)

(463)

Loss from discontinued operations, net of tax.............................................................................

-

(19)

 

 

Net loss...............................................................................................................................................

(1,756)

(482)

Other comprehensive income (loss):

Foreign currency translation......................................................................................................

204

(70)

 

 

Total comprehensive loss................................................................................................................

$ (1,552)

$ (552)

 

 

Net loss for diluted net loss per share...........................................................................................

$ (1,756)

$ (482)

 

 

Basic and diluted net loss per share from continuing operations.............................................

$ (0.02)

$ (0.01)

Basic and diluted net loss per share from discontinued operations.........................................

$ (0.00)

$ (0.00)

 

 

Basic and diluted net loss per share...............................................................................................

$ (0.02)

$ (0.01)

 

 

Basic and diluted weighted average shares outstanding...........................................................

76,060

52,456

 

 

 

FINANCIAL STATEMENTS

PROPHOTONIX LIMITED

 CONSOLIDATED BALANCE SHEETS

(unaudited)

 ($ in thousands except share and per share data)

 

For the Periods Ended June 30, 2012 and 2011

 

2012

 

2011

 

Assets

Current assets:

Cash and cash equivalents

$ 2,953

$ 568

Accounts receivable, less allowances of $30 in 2012 and $13 in 2011

1,976

2,423

Inventories

1,835

2,052

Prepaid expenses and other current assets

285

195

 

 

Total current assets

7,049

5,238

Net property, plant and equipment

568

838

Goodwill

444

508

Acquired intangible assets, net

265

477

Other long-term assets

35

41

 

 

Total assets

$ 8,361

$ 7,102

 

 

Liabilities and Stockholders' Equity (Deficit)

Current liabilities:

Revolving credit facility

$ 752

$ 798

Current portion of long-term debt

1,268

600

Capital lease obligations

10

10

Accounts payable

1,559

1,469

Income taxes payable

-

73

Accrued expenses

921

1,137

 

 

Total current liabilities

4,510

4,087

Long-term debt, net of current portion

1,517

3,332

Long-term capital lease obligation, net of current portion

14

-

Other long-term liabilities

178

178

 

 

Total liabilities

6,219

7,597

 

 

Stockholders' equity (deficit):

Common stock, par value $0.001; shares authorized 150,000,000 at June 30, 2012 and December 31, 2011; 76,059,477 shares issued and outstanding at June 30, 2012 and 52,810,174 shares issued at June 30, 2011.............................................

76

53

Paid-in capital

110,814

105,923

Accumulated deficit

(109,373)

(106,657)

Accumulated other comprehensive income

625

186

 

 

Total stockholders' equity (deficit)

2,142

(495)

 

 

Total liabilities and stockholders' equity (deficit)

$ 8,361

$ 7,102

 

 

 

PROPHOTONIX LIMITED

CONSOLIDATED STATEMENTS OF CASH FLOWS

In thousands

(unaudited)

 

Six Months EndedJune 30,

 

2012

 

2011

 

Operations

Net loss................................................................................................................................

$ (1,756)

$ (482)

Loss from discontinued operations, net of tax......................................................................

-

(19)

 

 

Loss from continuing operations..........................................................................................

(1,756)

(463)

Adjustments to reconcile net loss to net cash used in operating activities:

Stock based compensation.........................................................................................

63

148

Depreciation and amortization..................................................................................

208

323

Foreign exchange gain...............................................................................................

220

8

Provision for inventories...........................................................................................

12

27

Provision for bad debts..............................................................................................

25

12

Other change in assets and liabilities:

Accounts receivable...................................................................................................

347

(283)

Inventories................................................................................................................

(208)

(81)

Prepaid expenses and other current assets..................................................................

(4)

43

Accounts payable.......................................................................................................

147

(634)

Income taxes payable................................................................................................

(29)

73

Accrued expenses.......................................................................................................

170

(223)

 

 

Net cash used in operating activities..............................................................................

(805)

(1,123)

Net cash used in discontinued operations..............................................................................

-

(19)

 

 

Net cash used in operating activities..............................................................................

(805)

(1,142)

Financing

Net proceeds from sale of common stock.............................................................................

-

98

Net borrowing of revolving credit facility.............................................................................

104

134

Principal repayment of long-term debt.................................................................................

(366)

(314)

 

 

Net cash used in financing activities..............................................................................

(262)

(82)

Investing

Purchase of plant and equipment..........................................................................................

(48)

(48)

 

 

Net cash used in investing activities..............................................................................

(48)

(32)

Effect of exchange rate on cash...........................................................................................

2

29

 

 

Net change in cash and equivalents............................................................................

(1,113)

(1,243)

Cash and equivalents, beginning of period.............................................................................

4,066

1,811

 

 

Cash and equivalents, end of period....................................................................

$ 2,953

$ 568

 

 

Supplemental disclosure of cash flow information:

Cash paid for interest...........................................................................................................

$ 127

$ 191

Assets acquired under lease arrangement...............................................................................

$ 27

$ -

Cash paid for taxes...............................................................................................................

$ -

$ 15

 

 

 

 

 

 

 

 

 

Notes to unaudited Interim Results

 

Basis of Presentation

 

The Company financial reports are issued under United States Generally Accepted Accounting Principles (GAAP). The Accompanying unaudited condensed consolidated financial reports reflect all adjustments of a normal recurring nature necessary for a fair statement of the (i) results of operations and comprehensive income (loss) for the six month periods ended 30 June 2012 and 2011; (ii) the financial position at 30 June 2012 and 30 June 2011; and (iii) the cash flows for the six month period ended 30 June 2012 and 2011. These interim results are not necessarily indicative of results for a full year or any other interim period.

 

 

Cautionary Statement

 

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical fact, including without limitation, those with respect to ProPhotonix's goals, plans and strategies set forth herein are forward-looking statements. The following important factors and uncertainties, among others, could cause actual results to differ materially from those described in these forward-looking statements: uncertainty that cash balances may not be sufficient to allow ProPhotonix to meet all of its business goals; uncertainty that ProPhotonix's new products will gain market acceptance; the risk that delays and unanticipated expenses in developing new products could delay the commercial release of those products and affect revenue estimates; the risk that one of our competitors could develop and bring to market a technology that is superior to those products that we are currently developing; and ProPhotonix's ability to capitalize on its significant research and development efforts by successfully marketing those products that the Company develops. Forward-looking statements represent management's current expectations and are inherently uncertain. All Company, brand, and product names are trademarks or registered trademarks of their respective holders. ProPhotonix undertakes no duty to update any of these forward-looking statements.

 

 

 

 

Use of Non-GAAP Financial Measures

 

The Company provides non-GAAP financial measures, such as EBITDA, to complement its consolidated financial statements presented in accordance with GAAP. Non-GAAP financial measures do not have any standardized definition and, therefore, are unlikely to be comparable to similar measures presented by other reporting companies. These non-GAAP financial measures are intended to supplement the user's overall understanding of the Company's current financial and operating performance and its prospects for the future. Specifically, the Company believes the non-GAAP results provide useful information to both management and investors by identifying certain expenses, gains and losses that, when excluded from the GAAP results, may provide additional understanding of the Company's core operating results or business performance, which management uses to evaluate financial performance for purposes of planning for future periods. However, these non-GAAP financial measures are not intended to supersede or replace the Company's GAAP results.

 

The Company uses EBITDA (earnings before interest, taxes, depreciation, amortization, stock-based compensation and impairment charges) as a non-GAAP financial measure in this press release. A reconciliation of net loss to EBITDA for the six months ended June 30, 2012 and 2011 is as follows:

 

(in thousands)

Six Months Ended June 30,

2012

2011

Net Loss

(1,756)

(482)

Loss from discontinued operations

-

19

Plus:

Interest and other expense, net

120

197

Depreciation

148

167

Intangible asset amortization

60

156

Stock based compensation

63

148

Tax provision (benefit)

(29)

73

EBITDA gain (loss)

(1,394)

278

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR DMGMRVGKGZZM
Date   Source Headline
16th Dec 20217:00 amRNSSale of ProPhotonix and cancelation of AIM Listing
17th Nov 20217:00 amRNSNotice of GM
11th Nov 202111:05 amRNSSecond Price Monitoring Extn
11th Nov 202111:00 amRNSPrice Monitoring Extension
11th Nov 20217:00 amRNSProPhotonix Announces Merger Agreement
2nd Nov 20217:00 amRNSProPhotonix Extends COBRA HyperSpec range
14th Sep 20217:00 amRNSProPhotonix announces the new UV COBRA Cure FX4
8th Sep 20217:00 amRNS2021 Half-year Report
9th Jun 20217:00 amRNSPosting of Annual Report and Accounts
2nd Jun 20217:00 amRNSNew Wavelengths added to UVC LED System
25th Mar 20217:00 amRNSResults for the year ended December 31, 2020
26th Jan 20217:00 amRNSNew Hyperspectral COBRA MultiSpec LED Line Light
16th Nov 20202:05 pmRNSSecond Price Monitoring Extn
16th Nov 20202:00 pmRNSPrice Monitoring Extension
12th Nov 20207:00 amRNSAdmission of Shares
10th Nov 20207:00 amRNSProPhotonix introduces 265nm UVC LED Lamp
9th Nov 20204:45 pmRNSResult of AGM and Director / PDMR Shareholdings
9th Oct 20207:00 amRNSPOSTING OF NOTICE OF ANNUAL GENERAL MEETING
8th Oct 20207:00 amRNSNew RGB-IR & RGB-White COBRA MultiSpec Line Lights
7th Oct 20203:07 pmRNSHolding(s) in Company
10th Sep 20207:00 amRNSINTERIM RESULTS FOR HALF YEAR ENDED JUNE 30, 2020
3rd Sep 20204:40 pmRNSSecond Price Monitoring Extn
3rd Sep 20204:35 pmRNSPrice Monitoring Extension
3rd Sep 20202:05 pmRNSSecond Price Monitoring Extn
3rd Sep 20202:00 pmRNSPrice Monitoring Extension
2nd Sep 20207:00 amRNSPROdigii Digital Lasers Range - 5 New Wavelengths
27th Aug 20207:00 amRNSRESULTS FOR THE YEAR ENDED DECEMBER 31, 2019
25th Aug 20201:47 pmRNSNOTICE OF EXTENSION OF RIGHTS PLAN
24th Jul 20207:00 amRNSHolding(s) in Company
16th Jul 20207:00 amRNSChange of Adviser and Director Disclosures
29th Jun 20207:00 amRNSCustom LED Backlight wins VSD Innovators Award
23rd Jun 20207:00 amRNSAccounts Reporting Extension & Trading Update
30th Apr 20207:00 amRNSDirectorate Change
9th Apr 20207:00 amRNSCOVID – 19 and Trading Update
19th Mar 20207:00 amRNS3 Year Framework Product Supply & IP Agreement
16th Mar 20207:00 amRNSProPhotonix - UV LED Water Disinfection
16th Jan 20207:00 amRNSTrading Update 2019
26th Nov 20197:00 amRNSHolding(s) in Company
10th Oct 20197:00 amRNS5-Year Master Purchase Agreement - Fortune 50 CGLM
12th Sep 20197:00 amRNSProPhotonix to Exhibit UV Lamps at Labelexpo 2019
6th Sep 20197:00 amRNSProPhotonix issues Half-year Report
3rd Sep 20197:00 amRNSNew High-Powered Red Laser Diode from Ushio
31st May 201911:59 amRNSProPhotonix Notification of Major Holdings
31st May 201911:58 amRNSProPhotonix Notification of Major Holdings
24th May 20197:00 amRNSPPIX Issues Director/PDMR Shareholding Notice
23rd May 20197:00 amRNSPPIX Issues Director/PDMR Shareholding Notice
17th May 20197:00 amRNSProPhotonix Announces Trading Update
16th May 20195:58 pmRNSPPIX Announces AGM Results and PDMR Shareholdings
16th May 20197:00 amRNSPPIX Offers New COBRA Cure Mini UV Curing System
9th Apr 20197:00 amRNSProPhotonix Honored by Vision Systems Design 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.